Emami share news, announcements and annual reports
NSE: EMAMILTDBSE: 531162Personal ProductsSmall Cap
Emami Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Oct 1995 on BSE, Aug 2006 on NSE
Last close ₹359.75down ₹11.15 (3.01%)BSE ₹359.85
Share price at the NSE close on 30 Oct 2026. Previous close ₹370.90.
30 Oct: open ₹371.10, high ₹371.50, low ₹357.00
52-week range of traded prices to 30 Oct 2026
₹357.00Low, 30 Oct 2026₹550.90High, 16 Dec 2025
- Next results date: the board meets on 5 Nov 2026 to consider: financial results, dividend and other business matters. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹15,440 Cr349th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 20.63
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 5.28
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 2.78%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 26.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 26.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.04
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 7,11,12257.5% delivered
Emami share news and announcements
1,119 announcements, routine notices left out, newest first. Page 22 of 23.
Oct 2009
15 Oct · Board meeting
Inter-alia, to consider, approve and take on record the Unaudited Financial Results of the Company for the Second Quarter ended September 30, 2009.6 Oct · Disclosure
Raj Kumar Goenka, being the authorized representative of the Promoters and Persons acting in concert in respect of Equity Shares of Emami Limited, has submitted to the Exchange the Disclosure under Regulation 7(1A) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 1997. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.1 Oct · Disclosure
Disclosure of acquisition of shares in terms of Regulation 7(3) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 1997, in reference to the disclosure received by the Company on September 24, 2009 from Shri Raj Kumar Goneka on behalf of the Promoters and / or Persons acting in concert under Regulation 7(1A) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 1997. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Sep 2009
17 Sep · Business
At the meeting of the Equity Shareholders of the Company held on September 11, 2009 convened on the direction of the High Court of Calcutta, the shareholders have approved the Scheme of Arrangement in terms of Section 391 to 394 of the Companies Act, 1956 between Emami Ltd, The Zandu Pharmaceutical Works Ltd and Emami Infrastructure Ltd.3 Sep · Limited Review Report
Auditors have conducted the limited review for the un-audited financial results for the quarter ended June 30,2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2009
18 Jul · Board meeting
Inter-alia, to consider, approve and take on record the Unaudited Financial Results of the Company for the First Quarter ended June 30, 2009.2 Jul · Business
Qualified Institutional Placement (QIP) of Emami Limited of Equity Shares of Rs.2/- each as determined by the Book Building Process under "Chapter XIIIA - Guidelines for Qualified Institutional Placement" of the SEBI (Disclosure and Investor Protection) Guidelines, 2000, as follows: "The duly authorised committee of the Board of Directors viz. Share Transfer and Shareholders / Investors Grievance Committee, at its meeting held on July 2, 2009 has decided to close the issue and has approved the issuance of 1,00,00,000 (One Crore) Equity Shares of Rs.2/- each for cash at a price Rs.310/- per Equity Share (including a premium of Rs. 308/- per Equity Share) aggregating to Rs.310/- Crore (Rupees Three Hundred and Ten Crore only)".
Jun 2009
19 Jun · Board meeting
Board of Directors of the Company and The Zandu Pharmaceutical Works Limited ("Zandu") today approved:- (a) the demerger of the Realty Undertaking of Emami Limited into a separate company viz. Slick Properties Private Limited to be renamed as 'Emami Infrastructure Limited'. (b) the demerger of the FMCG Undertaking of Zandu into Emami Limited. (c) Realty Undertaking of Emami Limited includes its investment in wholly owned subsidiary Emami Realty Limited and its investment in equity shares of Zandu representing the carrying value of investment in the remaining business after the demerger of the Zandu's FMCG Undertaking i.e. Zandu's non-core undertaking. The Zandu's non-core undertaking to be renamed as "Zandu Realty Limited", each of the demergers shall be conditional upon the other". The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.17 Jun · Board meeting
To inter-alia, consider and approve the Scheme of Arrangement for restructuring and reorganizing of FMCG and Realty business being carried on by Emami Ltd and its subsidiary Companies i.e. the Zandu Pharmaceutical Works Ltd and Emami Realty Ltd.1 Jun · Limited Review Report
Auditors have conducted the limited review for the un-audited financial results for the quarter and year ended March 31, 2009. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Apr 2009
21 Apr · Board meeting
Meeting on 29 Apr 2009: “Unaudited Financial Results for the qtr ended March 31, 2009”
Mar 2009
30 Mar · Board meeting
Board of Directors of the Company has, in its meeting held on March 30, 2009, discussed various options for restructuring and reorganizing FMCG and Realty business carried on by Emami Ltd and subsidiaries i.e. Zandu Pharmaceutical Works Ltd and Emami Realty Ltd and authorized and empowered the Committee of the Board of Directors of the Company constituted for this purpose, to do the followings: (1) To examine and evaluate restructuring and reorganizing of FMCG and realty business being carried on by these companies through merger, demerger or any other arrangement. (2) To appoint advocates, legal advisors, valuers, merchant bankers and any other experts for taking their views and opinions in this respect; (3) To frame appropriate scheme and recommend to the Board of Directors of the Company; (4) To do all such acts and deeds which are necessary in this respect.26 Mar · Board meeting
Inter-alia, to discuss and consider various options of restructuring and reorganizing the business of the Company and its Subsidiary Companies viz. The Zandu Pharmaceutical Works Ltd and Emami Realty Ltd.13 Mar · Limited Review Report
Auditor's have conducted the limited review of the Unaudited financial results for the quarter ended December 31, 2008. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.13 Mar · Disclosure
Disclosure of acquisition of shares in terms of Regulation 7(3) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 1997. A copy of the disclosure shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.12 Mar · Disclosure
Disclosure under Regulation 7(1A) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 1997. A copy of the disclosure shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.2 Mar · Notice
Notice under Section 302 of the Companies Act, 1956 for terms of reappointment of the Executive Chairman Shri R.S. Agarwal. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Feb 2009
11 Feb · Disclosure
Disclosure under Regulation 8A(4) of SEBI (Substantial Acquisition of Shares and Takeovers)(Amendment) Regulations 2009. The copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2009
12 Jan · Board meeting
Company had informed the Exchange that the Meeting of Board of Directors of the Company is scheduled to be held on January 27, 2009, inter-alia to consider, approve and take on record unaudited Financial Results of the Company for the third quarter ended December 31, 2008. The Company has now informed the Exchange that the aforesaid meeting has been re-scheduled on January 28, 2009 instead of January 27, 2009.5 Jan · Board meeting
Meeting on 27 Jan 2009: “Unaudited Financial Results for the qtr ended Dec 31, 2008”
Nov 2008
18 Nov · Limited Review Report
Auditor's have conducted the limited review of the Unaudited financial results for the quarter ended September 30, 2008. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.7 Nov · Results
Result of the voting conducted through Postal Ballot under Section 192A of the Companies Act, 1956 on the resolutions set out in Notice dated October 03, 2008. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.4 Nov · Subsidiary
Consequent upon completion of the Open Offer to acquire 1,61,280 equity shares i.e. 20% of the votings rights of the Zandu Pharmaceutical Works Limited (Zandu) by Emami Limited, the aggregate shareholding of Emami Limited in Zandu has become 66.44% of the total paid up equity share capital of Zandu on November 03, 2008. By virtue of the aforesaid shareholding, The Zandu Pharmaceutical Works Limited has become Subsidiary Company of Emami Limited.
Oct 2008
23 Oct · Divestment
At the meeting of Board of Directors of the Company held on October 21, 2008, the Board has inter-alia decided to divest its entire stake/ shares held in its wholly subsidiary Company "Emami Realty Limited".16 Oct · Business
Vide its letter dated October 15, 2008, that: "Pursuant to the settlement efforts initiated by the Hon'ble Company Law Board vide its order dated 22nd September, 2008, the Company has acquired, in terms of a Share Purchase Agreement entered with the existing promoters of The Zandu Pharmaceuticals Works Limited (Zandu) and their relatives, friends and associates, 146643 equity shares comprising of 18.18% of the total paid up capital of Zandu at a price of Rs 15,000/- (Rupees Fifteen Thousand only) per share and also a non compete fee of Rs 1500/- (Rupees One Thousand five hundred only) per equity share. Please be further informed that by separate transactions, the company has today further acquired 37417 Equity shares of Zandu, as per details given herein under: i) No of Shares - 4103; % of paid up Equity Capital - 0.51%; Price per share - 14440.90. ii) No of Shares - 33314; % of paid up Equity Capital - 4.13%; Price per share - 14356.65".15 Oct · Board meeting
Meeting on 21 Oct 2008: “Unaudited financial results for qtr ended September 30, 2008”6 Oct · Corrigendum
Acquirer along with PACs have revised the Offer Price in respect of the Public Offer made by Emami Limited for acquisition of Equity Shares of The Zandu Pharmaceutical Works Limited from Rs. 15,000/- per equity share to Rs. 16,500/- per equity share. Further, Emami Limited has submitted to the Exchange a copy of Corrigendum published on October 03, 2008, with reference to Open Offer to acquire up to 1,61,280 equity shares representing up to 20% of the voting rights of The Zandu Pharmaceutical Works Limited (ZPWL) (Target Company) by Emami Limited (the Acquirer) and Bhanu Vyapaar Private Limited (BVPL), Suraj Viniyog Private Limited (SVPL), Diwakar Viniyog Private Limited (DVPL) and Suntrack Commerce Private Limited (SCPL) collectively referred to as the 'Person Acting in Concert/ PAC's at a Offer Price of Rs. 16,500/- (Rupees Sixteen Thousand Five Hundred only) per equity share (Being the Offer Price revised from Rs. 15,000/- per equity Share to Rs. 16,500/- per equity share). A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.3 Oct · Board meeting
Board of Directors of the Company at its meeting held on October 03, 2008 decided, inter alia, the following business:1. Seeking Approval of the shareholders under section 372A of the Companies Act 1956 through postal ballot for making further investment up to a sum of Rs. 430 Crores (Rupees Four Hundred Thirty Crores only) in acquisition of shares of The Zandu Pharmaceuticals Works Ltd. which is in addition to existing limit / approval available with the Company. 2) Revising the limit of borrowings under section 293(1)(d) of the Companies Act, 1956 from Rs 500 Crores to Rs.1500 Crores subject to the approval of shareholders through Postal Ballot. 3) Alteration in clause 21 of other Object Clause of the Memorandum of Association of the Company by substituting the said clause with the new clause relating to power generation and distribution subject to the approval of shareholders through Postal Ballot. 4) Commencement of new business activities Coal Mining and Power Generation & Distribution subject to the approval of shareholders under section 149(2A) of the Companies Act,1956 through postal ballot.3 Oct · Updates
In terms of Regulation 26 of SEBI (Substantial Acquisition of Shares and Takeovers) Regulation 1997, the Company alongwith PACs have revised the offer price in respect of the Public Offer made by it for acquisition of Equity Shares of The Zandu Pharmaceutical Works Limited from Rs. 15,000/- per equity share to Rs. 16,500/- per equity share. As required under the aforesaid regulation 26 the Company is making suitable arrangements for issuing corrigendum to PA in all the newspapers in which the original public announcement were made
Sep 2008
22 Sep · Corrigendum
Corrigendum to Public Announcement with reference to Open Offer to acquire up to 1,61,280 equity shares representing up to 20% of the voting rights of the Zandu Pharmaceutical Works Limited (ZPWL) (Target Company) by Emami Limited (Acquirer) and Bhanu Vyapaar Private Limited (BVPL), Suraj Viniyog Private Limited (SVPL), Diwakar Viniyog Private Limited (DVPL) and Suntrack Commerce Private Limited (SCPL) collectively referred to as the 'Person Acting in Concert/ PAC's at a Offer Price of Rs. 15,000/- (Rupees Fifteen Thousand only) per equity Share (Being the Offer Price revised from Rs.7,315/- per equity share to Rs. 15000/- per equity share). A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.17 Sep · Meeting
Proceedings of the Annual General Meeting of the members of the Company held on August 25, 2008. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.15 Sep · Updates
In terms of Regulation 26 of SEBI (Substantial Acquisition of Shares and Takeovers) Regulation 1997, the Company has revised the offer price in respect of the Public Offer made by it for acquisition of Equity Shares of The Zandu Pharmaceutical Works Limited from Rs 7315/- to Rs 15,000/- per share. As required under the aforesaid regulation 26 the Company is making suitable arrangements for issuing corrigendum to Public Announcement in all the newspapers in which the original public announcement were made11 Sep · Disclosure
Disclosure Under SEBI (Prohobition of Insider Trading) Regulation, 1992 as on August 25, 2008. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Aug 2008
1 Aug · Results
Result of Postal Ballot under Section 192A of the Companies Act, 1956. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2008
30 Jul · Disclosure
Copy of disclosure received from Shri Ashish Goenka on behalf of the Promoters and/ or Persons acting in concert under Regulation 7(1A) of SEBI(SAST) Regulation, 1997. Disclosure under Regulation 7(3) shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.8 Jul · Board meeting
Meeting on 25 Jul 2008: “Unaudited Financial Results for the Qtr ended June 30, 2008”2 Jul · Meeting
Annual General Meeting of the company will be held on August 25, 2008. Further, the Register of Members and Share Transfer Books of the company will remain closed from August 21, 2008 to August 25, 2008 (both days inclusive) for the purpose of payment of dividend and AGM.
Jun 2008
24 Jun · Meeting
In accordance with the provisions of Section 192A of the Companies Act, 1956 read with the Companies (Passing of the Resolutions by Postal Ballot) Rules, 2001. The resolutions proposed to be passed for (1) Inter Corporate Investments. (2) Offer and Issue of Equity Shares to QIBs on Prefential Basis. (3) Borrowings limit. (4) Alteration in Articles of Association. (5) Commencement of New Business-Real Estate Activities. (6) Payment of Commission to the Non-Executive Independent Directors. The Board of Directors of the Company has appointed Mr. Vinod Kothari, Practising Company Secretary, as the Scrutinizer for conducting the Postal Ballot voting process. Duly completed postal ballot form should reach the scrutinizer on or before the close of business on July 18, 2008. After completion of his scrutiny, the Scrutinizer will submit his report to the Executive Chairman and in his absence to the Managing Director/a Wholetime Director of the Company. The results of the Postal Ballot will be declared on July 28, 2008. A copy of the notice of Postal Ballot shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
May 2008
30 May · Business
The Company has entered into the Share Purchase Agreement with some of the existing promoters of The Zandu Pharmaceuticals Works Limited for acquiring 1,02,409 Equity Shares i.e. 12.70% of the said Company. Consequent to the above, the aggregate shareholding of the Company alongwith its associate / group companies / PACs in The Zandu Pharmaceuticals Works Limited has become 27.51% of the equity share capital of said Company which obligates the company to give Open Offer for acquiring minimum 20% shares from the Public pursuant to the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 1997. The Company has decided to make an Open Offer to all the remaining equity shareholders of The Zandu Pharmaceuticals Works Limited for acquiring 1,61,280 Equity Shares i.e. 20% of the paid up equity share capital of the Target Company29 May · Board meeting
Apart from the other businesses transacted at the Board Meeting held on May 28, 2008, the following matters were also discussed and approved : (1) Subject to approval of shareholders under section 81(1A) of the Companies Act, 1956, and other statutory approvals, fresh equity shares of Rs.2/- each be issued to QIBs up to 15% of the post issued equity capital of the Company i.e. upto 1,09,66,796 shares at market price or such premium to the market price as the Board may decide in compliance with the guidelines issued by SEBI in this regard. The further details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.29 May · Updates
Details of Turnover, Provision for Taxation and Profit after Taxation of the Company for the year ended March 31, 2008 in Comparison with the previous year along with amount appropriated to reserve etc. in terms of Clause 20. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.28 May · Dividend
Board of Directors of the Company at its meeting held on May 28, 2008 has proposed Dividend of Rs. 4.50 per share, i.e. 225% on the share capital of the Company.22 May · Disclosure
Acquisition and sale of 11944 equity shares representing 0.0192% of the paid up share capital of Emami Limited, by the respective acquirer and seller, under the regulation 7(1A) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 1997. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.12 May · Board meeting
Inter-alia, to approve audited annual accounts and to consider and if thought fit, to recommend a dividend for the year ended March 31, 2008.
Apr 2008
21 Apr · Disclosure
Continual disclosure of the Company under the SEBI (Prohibition of Insider Trading) Regulations, 1992 as on March 31, 2008. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements) For more details click here.10 Apr · Results
We shall be publishing Audited Annual Accounts for the financial year ended 31st March 2008 within the stipulated period instead of publishing unaudited financial results for the fourth quarter ended 31st March 2008
Mar 2008
3 Mar · Limited Review Report
Auditor's have conducted the limited review of the Unaudited financial results for the quarter ended December 31, 2007. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2008
23 Jan · Board meeting
Meeting on 31 Jan 2008: “Unaudited Financial Results for the qtr ended Dec 31, 2007”
Nov 2007
6 Nov · Disclosure
Continual disclosures of the Company as on the date of AGM of the Company i.e. September 25, 2007. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).e For more details click here.
Oct 2007
30 Oct · Board meeting
Due to strike call in West Bengal on October 31, 2007, they have to postpone their Board Meeting which was to be held on October 31, 2007, to inter alia consider and approve unaudited Financial Results for Quarter ended September 30, 2007 on November 1, 2007.